Literature DB >> 14622241

Quantitative analysis of dopaminergic loss in relation to functional territories in MPTP-treated monkeys.

Caroline Jan1, Mathias Pessiglione, Léon Tremblay, Dominique Tandé, Etienne C Hirsch, Chantal François.   

Abstract

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication in primates results in a heterogeneous loss of dopamine in the striatum, predominating in the dorsal and caudal parts of the structure, causing functional impairment that appears to be essentially motor and cognitive. The aim of the present study was to quantify the loss of dopamine in relation to the anatomo-functional subdivisions of the striatum, and also of the pallidum and cortex of MPTP-treated monkeys. A severe loss of dopaminergic innervation was observed in both the sensorimotor and associative territories of all these structures in MPTP-treated monkeys. Comparatively, the limbic territories of all these structures were little affected. The preservation of dopaminergic innervation of the limbic part of cerebral structures may explain the preservation of motivational processes mediated by these limbic regions in MPTP-treated monkeys.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622241     DOI: 10.1046/j.1460-9568.2003.02946.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  15 in total

1.  Cortical glutamate levels decrease in a non-human primate model of dopamine deficiency.

Authors:  Z Zhang; J E Quintero; X T Fan; F Zhao; Y Ai; A Andersen; P Hardy; F Ling; G A Gerhardt
Journal:  Brain Res       Date:  2014-01-04       Impact factor: 3.252

2.  Primary motor cortex of the parkinsonian monkey: differential effects on the spontaneous activity of pyramidal tract-type neurons.

Authors:  Benjamin Pasquereau; Robert S Turner
Journal:  Cereb Cortex       Date:  2010-11-02       Impact factor: 5.357

3.  Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease.

Authors:  Carine Karachi; David Grabli; Frédéric A Bernard; Dominique Tandé; Nicolas Wattiez; Hayat Belaid; Eric Bardinet; Annick Prigent; Hans-Peter Nothacker; Stéphane Hunot; Andreas Hartmann; Stéphane Lehéricy; Etienne C Hirsch; Chantal François
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

4.  Modeling Parkinson's disease in primates: The MPTP model.

Authors:  Gregory Porras; Qin Li; Erwan Bezard
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

Review 5.  Pathophysiology of dyskinesia and behavioral disorders in non-human primates: the role of serotonergic fibers.

Authors:  Véronique Sgambato; Léon Tremblay
Journal:  J Neural Transm (Vienna)       Date:  2018-03-03       Impact factor: 3.575

6.  Pallidal stimulation suppresses pathological dysrhythmia in the parkinsonian motor cortex.

Authors:  Kevin W McCairn; Robert S Turner
Journal:  J Neurophysiol       Date:  2015-02-04       Impact factor: 2.714

Review 7.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

8.  Primary motor cortex of the parkinsonian monkey: altered encoding of active movement.

Authors:  Benjamin Pasquereau; Mahlon R DeLong; Robert S Turner
Journal:  Brain       Date:  2015-10-21       Impact factor: 13.501

Review 9.  Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine?

Authors:  R M Villalba; Y Smith
Journal:  Neuroscience       Date:  2013-07-16       Impact factor: 3.590

10.  Physical activity is linked to ceruloplasmin in the striatum of intact but not MPTP-treated primates.

Authors:  Rehana K Leak; Krassimira A Garbett; Amanda M Dettmer; Zhiming Zhang; Károly Mirnics; Judy L Cameron
Journal:  Cell Tissue Res       Date:  2012-09-02       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.